Topiramate Tablet
Product Images NDC 50090-6828

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50090-6828). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01)
Chemical structure of topiramate, showing its molecular framework with oxygen, sulfur, nitrogen, methyl, and other atoms arranged in a bicyclic arrangement including a sulfamate group.*
FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02)
A cumulative rate plot showing time to first seizure for Topiramate at 50 mg/day and 400 mg/day doses. The x-axis represents time in days up to 500, and the y-axis shows cumulative rates of first seizure. The graph compares two groups: Topiramate 50 mg/day (solid line) and 400 mg/day (dotted line), with statistical significance indicated (p = 0.0002).*
FDA Label Image

Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03)

Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03)
A bar graph comparing the change from baseline to double-blind phase in average monthly migraine periods per 30 days across treatment groups including placebo and Topamax (topiramate) at doses of 50 mg/day, 100 mg/day, and 200 mg/day. The graph displays data from two studies with significance levels indicated for 100 mg/day and 200 mg/day doses.*
FDA Label Image

Label Image (Lbl500906828)

Label Image (Lbl500906828)
Topiramate 50 mg oral tablet label from A-S Medication Solutions. The label indicates 90 orange, oblong tablets in the package. Storage instructions specify 68 to 77 degrees Fahrenheit and protection from moisture. The label also lists the NDC number 50090-6828-0 and advises to see the package insert for dosage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.